costus</i> nanoparticles effectively reduced NF-κB and TNF-α expression in periodontitis, with a more pronounced effect observed on day 5 compared with day 2, suggesting its potential as a therapeutic agent in managing periodontal inflammation. This evidence concerns the gene NFKB1 and periodontitis.